Trial intelligence / Profile preview

Gut microbiota depletion with antibiotics in healthy male volunteers

NL-OMON27808Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Mar 2012
Modality
Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of ciprofloxacin, vancomycin and metronidazole, sponsored by Amsterdam University Medical Center. Primary endpoints: Side effects, Laboratory parameters for inflammatory responses and 2 more. Started Mar 2012; status: active, not recruiting.

02

Drugs

ciprofloxacinvancomycinmetronidazole

Beyond the preview

Go deeper on NL-OMON27808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON27808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call